Bromfenac is a nonsteroidal anti-inflammatory drug (NSAID) for ophthalmic use. Ophthalmic NSAIDs are becoming a cornerstone for the management of ocular pain and inflammation. Their well-characterized anti-inflammatory activity, analgesic property, and established safety record have also made NSAIDs an important tool for optimizing surgical outcomes. Non-ophthalmic formulations of bromfenac were withdrawn in the US in 1998 due to cases of severe liver toxicity.[L43942,T239]
Synonyms
Bromfenacum
Bromfenac
2-amino-3-(4-bromobenzoyl)benzeneacetic acid
Bromfenac sodium
[2-Amino-3-(4-bromo-benzoyl)-phenyl]-acetic acid
Bromfenaco
Brand Names
Strenza Plus
Pred Phos - Brom
Bromsite 0.075%
Bromfenac
Pred Phos-Gati-Brom
Bromfenac Ophthalmic Solution 0.09%
Yellox
Apo-bromfenac
Xibrom
Eugia-bromfenac
Bromfenac Ophthalmic Solution, 0.07%
Bromday
Bromfenac Sodium
Bromfenac 0.075%
Bromfenac Ophthalmic Solution
Auro-bromfenac
Pred-Brom
Pred-Gati-Brom
Prolensa
Bromfenac Ophthalmic Solution, 0.09%
Indication
For the treatment of postoperative inflammation in patients who have undergone cataract extraction.
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison
T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS.
Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682